At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB Arts Media / Shutterstock. Eli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for treating pre-diabetic and obese individuals. Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy […]
Radella Pharmaceuticals’ MD-18 shows promise in Phase 1a results. (Credit: Bruno from Pixabay) Radella Pharmaceuticals, a clinical-stage biopharmaceutical company, has announced topline results from its Phase 1a study of MD-18, an investigational treatment for obesity and diabetes. The study evaluated MD-18’s safety, tolerability, and pharmacokinetics. MD-18 targets protein-tyrosine phosphatase 1B (PTP1B), a therapeutic target supporting […]
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.38 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 16.28%. A quarter ago, […]
Tandem Diabetes Care ( (TNDM) ) has released its Q3 earnings. Here is a breakdown of the information Tandem Diabetes Care presented to its investors. Tandem Diabetes Care is a global company specializing in insulin delivery and diabetes technology, known for its advanced automated insulin delivery systems, including the Tandem Mobi and t:slim X2 pumps […]
Welcome to Herbology News!
At Herbology News, we’re dedicated to empowering you with knowledge and resources to help you lead a healthier life naturally.
Herbologynews @2024. All Rights Reserved.
Subscribe to receive fresh content, tips, and insights delivered straight to your inbox—never miss a post again!
